World Health Organization (WHO) Risk Level Reductions in Inpatients With Alcohol Use Disorder and Comorbid Anxiety Disorders

被引:0
|
作者
Stevenson, Brittany L. [1 ,3 ]
Anker, Justin [1 ]
Thuras, Paul [2 ]
Rinehart, Linda [1 ]
Kushner, Matt G. [1 ]
机构
[1] Univ Minnesota, Dept Psychiat & Behav Sci, Minneapolis, MN USA
[2] Minneapolis Vet Affairs, One Vet Dr, Minneapolis, MN USA
[3] Univ Minnesota, Dept Psychiat & Behav Sci, 2450 Riverside Ave, Minneapolis, MN 55454 USA
关键词
harm reduction; inpatient; alcohol use disorder; alcohol dependence; treatment outcomes; CONTROLLED DRINKING; GOAL CHOICE; DEPENDENCE; CONSUMPTION; THERAPY;
D O I
10.1037/adb0000895
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: Studies have demonstrated that reduced drinking without total abstinence is associated with improved outcomes in outpatients with alcohol use disorder (AUD). We sought to examine this question in AUD inpatients who have comorbid anxiety disorders, a common presentation in AUD. Method: This is a secondary analysis of data from a randomized controlled trial for N = 241 inpatients with AUD and comorbid anxiety disorders. Change from baseline drinking level was measured at 1-, 4-, and 12-months postdischarge, and psychological and functional outcomes were measured at 4- and 12-months postdischarge. Three groups were compared: abstinent, reduced (reduced drinking by 1-3 World Health Organization drinking risk levels without abstinence), or nonreduced (maintained or increased drinking risk level). Results: At 1-, 4-, and 12-months posttreatment, most patients reported abstinence (83, 63, and 60%), and 11, 25, and 26% reported drinking at a reduced level. Drinking reductions achieved at 1-month posttreatment were maintained at 12-month posttreatment by 74% of participants. Overall, the abstinent group reported the best psychological and functional outcomes at follow-ups, followed by the reduced group. Few differences were observed between reducers and nonreducers, but reducers reported significantly better alcohol dependence severity and alcohol-related problems than nonreducers. Conclusions: Though abstinence was associated with the best outcomes in this abstinence-based treatment sample, we conclude that reduced drinking is also associated with significant improvements in alcohol-related outcomes in inpatients with AUD and comorbid anxiety disorders. Public Health Significance Statement The results of this study indicate that reducing one's drinking by one to three WHO risk levels following inpatient treatment is associated with beneficial alcohol-related outcomes (e.g., fewer alcohol-related problems) at 1-year posttreatment. However, abstinence was associated with larger improvement in psychological outcomes than reducing drinking, as well as some functional outcomes (e.g., more days of work, fewer interpersonal problems).
引用
收藏
页码:713 / 722
页数:10
相关论文
共 50 条
  • [21] Influence of comorbid alcohol use disorders on the clinical patterns of major depressive disorder: A general population-based study
    Carton, Louise
    Pignon, Baptiste
    Baguet, Alexandre
    Benradia, Imane
    Roelandt, Jean-Luc
    Vaiva, Guillaume
    Thomas, Pierre
    Amad, Ali
    De Timary, Philippe
    Naassila, Mickael
    Geoffroy, Pierre A.
    Rolland, Benjamin
    DRUG AND ALCOHOL DEPENDENCE, 2018, 187 : 40 - 47
  • [22] Does Comorbid Anxiety or Depression Moderate Effects of Approach Bias Modification in the Treatment of Alcohol Use Disorders?
    Salemink, Elske
    Rinck, Mike
    Becker, Eni
    Wiers, Reinout W.
    Lindenmeyer, Johannes
    PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2022, 36 (05) : 547 - 554
  • [23] The Clinical and Theoretical Basis for Integrated Cognitive Behavioral Treatment of Comorbid Social Anxiety and Alcohol Use Disorders
    Stapinski, Lexine A.
    Rapee, Ronald M.
    Sannibale, Claudia
    Teesson, Maree
    Haber, Paul S.
    Baillie, Andrew J.
    COGNITIVE AND BEHAVIORAL PRACTICE, 2015, 22 (04) : 504 - 521
  • [24] Trait Impulsivity Is Increased in Bipolar Disorder Patients with Comorbid Alcohol Use Disorders
    Nery, Fabiano G.
    Hatch, John P.
    Monkul, E. Serap
    Matsuo, Koji
    Zunta-Soares, Giovana B.
    Bowden, Charles L.
    Soares, Jair C.
    PSYCHOPATHOLOGY, 2013, 46 (03) : 145 - 152
  • [25] A Distinct Neurophenotype of Fearful Face Processing in Alcohol Use Disorder With and Without Comorbid Anxiety
    MacIlvane, Nicole
    Fede, Samantha J.
    Pearson, Emma E.
    Diazgranados, Nancy
    Momenan, Reza
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 44 (11): : 2212 - 2224
  • [26] Causal Network Modeling of the Determinants of Drinking Behavior in Comorbid Alcohol Use and Anxiety Disorder
    Anker, Justin J.
    Kummerfeld, Erich
    Rix, Alexander
    Burwell, Scott J.
    Kushner, Matt G.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 (01) : 91 - 97
  • [27] Comparisons of insight in schizophrenia, bipolar I disorder, and depressive disorders with and without comorbid alcohol use disorder
    Yen, Cheng-Fang
    Chen, Cheng-Chung
    Cheng, Chung-Ping
    Yen, Chia-Nan
    Lin, Huang-Chi
    Ko, Chih-Hung
    Yen, Ju-Yu
    Chen, Cheng-Sheng
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2008, 62 (06) : 685 - 690
  • [28] The main clinical-dynamic characteristics of alcohol use disorder comorbid with mood disorders
    Roshchina, O.
    Simutkin, G.
    Schastnyy, E.
    Bokhan, N.
    Mandel, A.
    EUROPEAN PSYCHIATRY, 2020, 63 : S96 - S96
  • [29] Concurrent use of alcohol with other drugs and DSM-5 alcohol use disorder comorbid with other drug use disorders: Sociodemographic characteristics, severity, and psychopathology
    Saha, Tulshi D.
    Grant, Bridget F.
    Chou, S. Patricia
    Kerridge, Bradley T.
    Pickering, Roger P.
    Ruan, W. June
    DRUG AND ALCOHOL DEPENDENCE, 2018, 187 : 261 - 269
  • [30] Alcohol Use Disorder and HIV Risk in a National Survey of Men Who Have Sex with Men in Ukraine
    Gabriel, Walter
    Sazonova, Yana
    Kulchynska, Roksolana
    Lamonaca, Katherine
    Salyuk, Tatiana
    Smyrnov, Pavlo
    Altice, Frederick L.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2024,